PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1882992
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1882992
Rotavirus Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of rotavirus vaccines Market
The global rotavirus vaccines market continues to expand as vaccination coverage improves worldwide and governments strengthen their immunization programs. According to the report, the global rotavirus vaccines market size reached USD 5.19 billion in 2024, is projected to rise to USD 5.22 billion in 2025, and is expected to grow significantly to USD 10.21 billion by 2032, reflecting a strong CAGR of 10.1% during the forecast period. In 2024, North America accounted for the largest share at 38.53%, supported by strong healthcare systems and high vaccination uptake.
Rotavirus is one of the most common causes of severe gastrointestinal infections among infants and young children, leading to diarrhea, vomiting, and dehydration. Nearly all children in the U.S. contract a rotavirus infection by the age of five. With rising awareness, increasing healthcare spending, and strong government-supported vaccination programs, the adoption of rotavirus vaccines has increased significantly worldwide. According to CDC data released in April 2024, over 400,000 patients visit a doctor for rotavirus infection each year in the U.S., and nearly 200,000 visit emergency rooms, emphasizing the critical need for widespread vaccination.
Market Drivers
A major driver for market growth is the growing implementation of national immunization programs in the U.S., Europe, India, and other regions. Countries such as the U.S., France, and Germany include rotavirus vaccines as part of their routine childhood immunizations, raising vaccination coverage. In India, following the recommendation of the National Technical Advisory Group on Immunization (NTAGI), the government integrated the rotavirus vaccine under the Universal Immunization Programme (UIP), widely expanding access. Increased global awareness of rotavirus-associated mortality and morbidity continues to boost adoption.
Market Restraints
Supply chain limitations pose a significant challenge to market expansion. Maintaining appropriate cold chain and transportation standards remains difficult in low-resource regions. UNICEF reported in October 2024 that several countries had to switch vaccine suppliers due to supply shortages from a leading manufacturer, disrupting immunization schedules. Such issues reduce vaccine availability and directly affect vaccination rates and market growth.
Market Opportunities
The future offers strong opportunities as more countries incorporate rotavirus vaccines into public immunization schedules. Growing awareness campaigns, new product launches, and cost-effective vaccines are increasing global vaccination coverage. In October 2024, Chad introduced rotavirus vaccines through its Expanded Programme on Immunization, joining multiple African nations striving for improved pediatric health. Rising healthcare investments in India, China, and Southeast Asia also present growth opportunities as governments work to reduce diarrheal disease burden among children.
Market Challenges
While rotavirus vaccines are widely beneficial, safety concerns such as the risk of intussusception-a bowel blockage-continue to challenge public perception. According to CDC data from December 2024, studies show a slight increase in the risk of intussusception after vaccination. Negative community discussions can hinder vaccination rates in sensitive regions, making public education crucial for continued market growth.
Market Trends
A notable trend shaping the market is the development of innovative vaccine formulations beyond oral administration. Oral vaccines are convenient but face challenges such as low bioavailability due to enzyme degradation and first-pass metabolism. To improve efficacy, researchers are developing next-generation delivery technologies. In June 2025, Emory University and Micron Biomedical announced the first clinical trial of CC24, a rotavirus vaccine delivered via dissolvable microarray patches. Meanwhile, progress continues in developing parenteral vaccine candidates, opening opportunities for improved immune response and broader accessibility.
Regional Overview
North America
North America dominated the market in 2024 with a valuation of USD 2.00 billion, driven by high disease awareness, strong R&D capabilities, and robust cold chain infrastructure. The U.S. led the region with high vaccination rates and ongoing product approvals supported by CDC recommendations.
Europe
Europe held a substantial share in 2024 due to widespread government support. The region reports 75,000-150,000 annual hospitalizations caused by rotavirus gastroenteritis, motivating strong uptake of ROTARIX and RotaTeq since their approval in 2006.
Asia Pacific
Asia Pacific is the fastest-growing region, driven by a large pediatric population and increasing government initiatives. Surveillance data showed that 40.8% of childhood diarrheal disease cases in Southeast Asia were due to rotavirus.
Latin America & Middle East & Africa
These regions continue to expand vaccination efforts with support from Gavi and UNICEF, enabling affordable access and improving immunization rates.
Conclusion
Growing from USD 5.19 billion in 2024 to USD 5.22 billion in 2025 and reaching USD 10.21 billion by 2032, the rotavirus vaccines market is positioned for strong growth. With rising vaccination coverage, ongoing innovation, and government-backed immunization programs, the global market will continue to expand rapidly in the years ahead.
Segmentation By Type
- Live Attenuated
- Others
By Product
- ROTARIX
- RotaTeq
- ROTASIIL
- ROTOVAC
- Others
By Distribution Channel
- Hospital & Retail Pharmacies
- Government Suppliers
- Others
By Geography
- North America (By Type, Product, Distribution Channel, and Country/Sub-region)
- U.S.
- Canada
- Europe (By Type, Product, Distribution Channel, and Country/Sub-region)
- Germany
- U.K.
- France
- Spain
- Italy
- Scandinavia
- Rest of Europe
- Asia Pacific (By Type, Product, Distribution Channel, and Country/Sub-region)
- China
- Japan
- India
- Australia
- Southeast Asia
- South Korea
- Rest of Asia Pacific
- Latin America (By Type, Product, Distribution Channel, and Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Type, Product, Distribution Channel, and Country/Sub-region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Incidence/Prevalence of Rotavirus Infection, 2024
- 4.2. New Product Launches, By Key Players
- 4.3. Pipeline Analysis, By Key Players
- 4.4. Recommendations/Guidelines for Rotavirus Vaccines
- 4.5. Overview: Vaccination Schedule for Rotavirus
- 4.6. Technological Advancements in the Rotavirus Vaccines
- 4.7. Key Industry Developments Such as Mergers, Acquisitions, and Partnerships
5. Global Rotavirus Vaccines Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast - By Type
- 5.1.1. Live Attenuated
- 5.1.2. Others
- 5.2. Market Analysis, Insights and Forecast - By Product
- 5.2.1. ROTARIX
- 5.2.2. RotaTeq
- 5.2.3. ROTASIIL
- 5.2.4. ROTOVAC
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast - By Distribution Channel
- 5.3.1. Hospital & Retail Pharmacies
- 5.3.2. Government Suppliers
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Rotavirus Vaccines Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast - By Type
- 6.1.1. Live Attenuated
- 6.1.2. Others
- 6.2. Market Analysis, Insights and Forecast - By Product
- 6.2.1. ROTARIX
- 6.2.2. RotaTeq
- 6.2.3. ROTASIIL
- 6.2.4. ROTOVAC
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast - By Distribution Channel
- 6.3.1. Hospital & Retail Pharmacies
- 6.3.2. Government Suppliers
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe Rotavirus Vaccines Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast - By Type
- 7.1.1. Live Attenuated
- 7.1.2. Others
- 7.2. Market Analysis, Insights and Forecast - By Product
- 7.2.1. ROTARIX
- 7.2.2. RotaTeq
- 7.2.3. ROTASIIL
- 7.2.4. ROTOVAC
- 7.2.5. Others
- 7.3. Market Analysis, Insights and Forecast - By Distribution Channel
- 7.3.1. Hospital & Retail Pharmacies
- 7.3.2. Government Suppliers
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.4.1. U.K.
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Spain
- 7.4.5. Italy
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
8. Asia Pacific Rotavirus Vaccines Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast - By Type
- 8.1.1. Live Attenuated
- 8.1.2. Others
- 8.2. Market Analysis, Insights and Forecast - By Product
- 8.2.1. ROTARIX
- 8.2.2. RotaTeq
- 8.2.3. ROTASIIL
- 8.2.4. ROTOVAC
- 8.2.5. Others
- 8.3. Market Analysis, Insights and Forecast - By Distribution Channel
- 8.3.1. Hospital & Retail Pharmacies
- 8.3.2. Government Suppliers
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.4.1. Japan
- 8.4.2. China
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America Rotavirus Vaccines Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast - By Type
- 9.1.1. Live Attenuated
- 9.1.2. Others
- 9.2. Market Analysis, Insights and Forecast - By Product
- 9.2.1. ROTARIX
- 9.2.2. RotaTeq
- 9.2.3. ROTASIIL
- 9.2.4. ROTOVAC
- 9.2.5. Others
- 9.3. Market Analysis, Insights and Forecast - By Distribution Channel
- 9.3.1. Hospital & Retail Pharmacies
- 9.3.2. Government Suppliers
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
10. Middle East & Africa Rotavirus Vaccines Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast - By Type
- 10.1.1. Live Attenuated
- 10.1.2. Others
- 10.2. Market Analysis, Insights and Forecast - By Product
- 10.2.1. ROTARIX
- 10.2.2. RotaTeq
- 10.2.3. ROTASIIL
- 10.2.4. ROTOVAC
- 10.2.5. Others
- 10.3. Market Analysis, Insights and Forecast - By Distribution Channel
- 10.3.1. Hospital & Retail Pharmacies
- 10.3.2. Government Suppliers
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.4.1. GCC
- 10.4.2. South Africa
- 10.4.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2024)
- 11.2. Company Profiles
- 11.2.1. GSK plc
- 11.2.1.1. Overview
- 11.2.1.2. Services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Merck & Co. Inc.
- 11.2.2.1. Overview
- 11.2.2.2. Services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. Serum Institute of India Pvt. Ltd.
- 11.2.3.1. Overview
- 11.2.3.2. Services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Sanofi
- 11.2.4.1. Overview
- 11.2.4.2. Services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Bharat Biotech
- 11.2.5.1. Overview
- 11.2.5.2. Services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. SINOVAC
- 11.2.6.1. Overview
- 11.2.6.2. Services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.1. GSK plc
List of Tables
- Table 1: Global Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032
- Table 2: Global Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2032
- Table 3: Global Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 4: Global Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Region, 2019-2032
- Table 5: North America Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032
- Table 6: North America Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2032
- Table 7: North America Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 8: North America Rotavirus Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032
- Table 9: Europe Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032
- Table 10: Europe Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2032
- Table 11: Europe Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 12: Europe Rotavirus Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
- Table 13: Asia Pacific Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032
- Table 14: Asia Pacific Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2032
- Table 15: Asia Pacific Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 16: Asia Pacific Rotavirus Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
- Table 17: Latin America Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032
- Table 18: Latin America Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2032
- Table 19: Latin America Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 20: Latin America Rotavirus Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
- Table 21: Middle East & Africa Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Type, 2019-2032
- Table 22: Middle East & Africa Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2032
- Table 23: Middle East & Africa Rotavirus Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 24: Middle East & Africa Rotavirus Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
List of Figures
- Figure 1: Global Rotavirus Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
- Figure 2: Global Rotavirus Vaccines Market Value Share (%), by Type, 2024 & 2032
- Figure 3: Global Rotavirus Vaccines Market Value Share (%), by Product, 2024 & 2032
- Figure 4: Global Rotavirus Vaccines Market Value Share (%), by Distribution Channel, 2024 & 2032
- Figure 5: Global Rotavirus Vaccines Market Value Share (%), by Region, 2024 & 2032
- Figure 6: North America Rotavirus Vaccines Market Value (USD billion), by Type, 2024 & 2032
- Figure 7: North America Rotavirus Vaccines Market Value Share (%), by Type, 2024
- Figure 8: North America Rotavirus Vaccines Market Value (USD billion), by Product, 2024 & 2032
- Figure 9: North America Rotavirus Vaccines Market Value Share (%), by Product, 2024
- Figure 10: North America Rotavirus Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 11: North America Rotavirus Vaccines Market Value Share (%), by Distribution Channel, 2024
- Figure 12: North America Rotavirus Vaccines Market Value (USD billion), By Country, 2024 & 2032
- Figure 13: North America Rotavirus Vaccines Market Value Share (%), By Country, 2024
- Figure 14: Europe Rotavirus Vaccines Market Value (USD billion), by Type, 2024 & 2032
- Figure 15: Europe Rotavirus Vaccines Market Value Share (%), by Type, 2024
- Figure 16: Europe Rotavirus Vaccines Market Value (USD billion), by Product, 2024 & 2032
- Figure 17: Europe Rotavirus Vaccines Market Value Share (%), by Product, 2024
- Figure 18: Europe Rotavirus Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 19: Europe Rotavirus Vaccines Market Value Share (%), by Distribution Channel, 2024
- Figure 20: Europe Rotavirus Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
- Figure 21: Europe Rotavirus Vaccines Market Value Share (%), By Country/ Sub-region, 2024
- Figure 22: Asia Pacific Rotavirus Vaccines Market Value (USD billion), by Type, 2024 & 2032
- Figure 23: Asia Pacific Rotavirus Vaccines Market Value Share (%), by Type, 2024
- Figure 24: Asia Pacific Rotavirus Vaccines Market Value (USD billion), by Product, 2024 & 2032
- Figure 25: Asia Pacific Rotavirus Vaccines Market Value Share (%), by Product, 2024
- Figure 26: Asia Pacific Rotavirus Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 27: Asia Pacific Rotavirus Vaccines Market Value Share (%), by Distribution Channel, 2024
- Figure 28: Asia Pacific Rotavirus Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
- Figure 29: Asia Pacific Rotavirus Vaccines Market Value Share (%), By Country/ Sub-region, 2024
- Figure 30: Latin America Rotavirus Vaccines Market Value (USD billion), by Type, 2024 & 2032
- Figure 31: Latin America Rotavirus Vaccines Market Value Share (%), by Type, 2024
- Figure 32: Latin America Rotavirus Vaccines Market Value (USD billion), by Product, 2024 & 2032
- Figure 33: Latin America Rotavirus Vaccines Market Value Share (%), by Product, 2024
- Figure 34: Latin America Rotavirus Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 35: Latin America Rotavirus Vaccines Market Value Share (%), by Distribution Channel, 2024
- Figure 36: Latin America Rotavirus Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
- Figure 37: Latin America Rotavirus Vaccines Market Value Share (%), By Country/ Sub-region, 2024
- Figure 38: Middle East & Africa Rotavirus Vaccines Market Value (USD billion), by Type, 2024 & 2032
- Figure 39: Middle East & Africa Rotavirus Vaccines Market Value Share (%), by Type, 2024
- Figure 40: Middle East & Africa Rotavirus Vaccines Market Value (USD billion), by Product, 2024 & 2032
- Figure 41: Middle East & Africa Rotavirus Vaccines Market Value Share (%), by Product, 2024
- Figure 42: Middle East & Africa Rotavirus Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 43: Middle East & Africa Rotavirus Vaccines Market Value Share (%), by Distribution Channel, 2024
- Figure 44: Middle East & Africa Rotavirus Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
- Figure 45: Middle East & Africa Rotavirus Vaccines Market Value Share (%), By Country/ Sub-region, 2024
- Figure 46: Global Rotavirus Vaccines Market Share (%), By Company, 2024
